letrozole has been researched along with Basal Ganglia Diseases in 1 studies
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Excerpt | Relevance | Reference |
---|---|---|
"Mrs A, a 68-year-old woman with paranoid schizophrenia, was on long-term psychiatric treatment with long-acting intramuscular zuclopenthixol, quetiapine and alprazolam when, in April 2012, she was diagnosed with right breast infiltrating ductal carcinoma." | 3.81 | Possible interaction between letrozole and long-acting injectable zuclopenthixol. ( Aguirre, C; Albeniz, JM; Echaburu, SD; García, MG; Hernandez, R; Lertxundi, U; Ruiz, B, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lertxundi, U | 1 |
Hernandez, R | 1 |
Albeniz, JM | 1 |
Echaburu, SD | 1 |
Ruiz, B | 1 |
García, MG | 1 |
Aguirre, C | 1 |
1 other study available for letrozole and Basal Ganglia Diseases
Article | Year |
---|---|
Possible interaction between letrozole and long-acting injectable zuclopenthixol.
Topics: Aged; Antineoplastic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Dibenzothia | 2015 |